Once a buzzword, the "digital middle platform" is now mired in what Gartner calls the "trough of disillusionment" —data keeps ...

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Aurora Mobile Third Quarter 2025 Earnings ...

A new app from Zoho targets teams that like to collaborate and work visually rather than solely in messages and documents.

PGY's strong rally, resilient AI-driven model and discounted valuation highlight upside potential, though rising costs may cloud near-term growth.

Learn how advances in stabilization, automation, and SR-DLS are making PEI-based transient transfection more efficient, ...

GitLab's new hybrid pricing model and operational leverage from AI tools support significant margin expansion. Read why GTLB stock is a Strong Buy.

Enterprises today are equipped with a vast array of tools and technologies. The opportunity lies in bringing these ...

Possibly the most absurd truth of modern computing is that, as far as the technology has evolved, we're fundamentally still doing the exact same thing we were doing decades ago: twiddling bits. The ...

As artificial intelligence moves deeper into healthcare, executive teams are grappling with how to make it operational, safe, and sustainable. During the AI Summit at Becker’s 13th Annual CEO+CFO ...